Chitosan monomer promotes tissue regeneration on dental pulp wounds

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 4, 2006, Pages 711-720

  Matsunaga, Tsunenori ^a   Yanagiguchi, Kajiro ^a   Yamada, Shizuka ^a   Ohara, Naoko ^a   Ikeda, Takeshi ^a   Hayashi, Yoshihiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase activity; D glucosamine hydrochloride; Direct pulp capping; Tissue regeneration; Wound healing

Indexed keywords

AMINES; CELL CULTURE; DENTISTRY; MEDICAL PROBLEMS; OSTEOBLASTS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE ACTIVITY; D-GLUCOSAMINE HYDROCHLORIDE; DIRECT PULP CAPPING; TISSUE REGENERATION; WOUND HEALING;

MONOMERS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; CYTOKINE; GLUCOSAMINE; INTERLEUKIN 8; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL INFILTRATION; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REGENERATION; TOOTH CROWN; TOOTH PULP DISEASE; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; PATHOPHYSIOLOGY; REGENERATION;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CHITOSAN; DENTAL PULP DISEASES; HUMANS; INTERLEUKIN-8; RATS; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745530253     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30588     Document Type: Article

References (40)

1. Asaoka K. Chitin/Chitosan, the Choice Food Supplement for Over 10,000 Physicians in Japan. New York: Vantage Press; 1996. p 143.
2. Koide SS. Chitin-chitosan: Properties, benefits and risks. Nutr Res 1998;18:1091-1101.
3. Hidaka Y, Ito M, Mori K, Yagasaki H, Kafrawy AH. Histopathological and immunohistochemical studies of membranes of deacetylated chitin derivatives implanted over rat calvaria. J Biomed Mater Res 1999;46:418-423.
4. Singla AK, Chawla M. Chitosan: Some pharmaceutical and biological aspects - An update. J Pharm Pharmacol 2001;53: 1047-1067.
5. Ikeda T, Yanagiguchi K, Hayashi Y. Application to dental medicine - In focus on dental caries and alveolar bone healing. BioIndustry 2002;19:22-30 (in Japanese).
6. Fujiwara M, Hayashi Y, Ohara N. Inhibitory effect of water-soluble chitosan on growth of Streptococcus mutans. Microbiologica 2004;27:83-86.
7. Huang M, Khor E, Kim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm Res 2004;21:344-353.
8. Shigemasa Y, Minami S. Application of chitin and chitosan for biomaterials. Biotech Genet Eng Rev 1996;13:383-420.
9. Muzzarelli RAA, Mattioli-Belmonte M, Pugnaloni A, Biagini G. Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. In: Jolles P, Muzzarelli RAA, editors. Chitin and Chitinases. Basel: Birkhauser Verlag; 1999. p 285-293.
10. Ikeda T, Yanagiguchi K, Viloria IL, Hayashi Y. Relationship between lysozyme activity and clinical symptoms following the application of chitin/chitosan in endodontic treatment. In: Muzzarelli RAA, editor. Chitosan Per Os: From Dietary Supplement to Drug Carrier. Crottammare: Atec Edizioni; 2000. p 275-292.
11. Mori T, Okumura M, Matsumura M, Ueno K, Tokura S, Okamoto Y, Minami S, Fujinaga T. Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials 1997;18:947-951.
12. Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, Kadosawa T, Fujinaga T. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 1999;20:1407-1414.
13. Lu JX, Prudhommeaux F, Meunier A, Sedel L, Guillemin G. Effects of chitosan on rat knee cartilages. Biomaterials 1999;20: 1937-1944.
14. Okamoto Y, Minami S, Matsuhashi A, Sashiwa H, Saimoto H, Shigemasa Y, Tanigawa T, Tanaka Y, Tokura S. Polymeric N-acetyl-D-glucosamine (chitin) induces histionic activation in dogs. J Vet Med Sci 1993;53:131-140.
15. Peluso G, Perillo O, Ranieri M, Santin M, Ambrosio L, Calbro D, Avallo B, Balsamo G. Chitosan-mediated stimulation of macrophage function. Biomaterials 1994;15:1215-1220.
16. Usami Y, Okamoto Y, Minami S, Matsuhashi A, Kumazawa N, Tanioka S, Shigemasa Y. Chitin and chitosan induce migration of bovine polymorphonuclear cells. J Vet Med Sci 1994;56:761-762.
17. Minami S, Masuda M, Suzuki H, Okamoto Y, Matsuhashi A, Kato K, Shigemasa Y. Subcutaneous injected chitosan induces systemic activation in dogs. Carbohydr Polym 1997;33:285-294.
18. Yanagiguchi K, Ikeda T, Takai F, Ogawa K, Hayashi Y. Wound healing following direct pulp capping with chitosan-ascorbic acid complex in rat incisors. In: Uragami T, Kurita K, Fukamizo T, editors. Chitin and Chitosan-Chitin and Chitosan in Life Science. Tokyo: Kodansha Scientific; 2001. p 240-242.
19. Yamada S, Ohara N, Hayashi Y. Mineralization of matrix vesicles isolated from a human osteosarcoma cell line in culture with water-soluble chitosan-containing medium. J Bone Miner Res 2003;66A:500-506.
20. Hotta T, Motoyama T, Watanabe H. Three human osteosarcoma cell lines exhibiting different phenotypic expressions. Acta Pathol Jpn 1992;42:595-603.
21. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:345-356.
22. Stanford CM, Welsch F, Kastner N, Thomas G, Zaharias R, Holtman K, Brand RA. Primary human bone cultures from older patients do not respond at continuum levels of in vivo strain magnitudes. J Biomech 2000;33:63-71.
23. Fleet JC, Hock JM. Identification of osteocalcin mRNA in non-osteoid tissue of rat and humans by reverse transcription polymerase chain reaction. J Bone Miner Res 1994;10:1565-1573.
24. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242: 1528-1534.
25. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-167.
26. Urist MR. Bone morphogenetic protein: The molecularization of skeletal system development. J Bone Miner Res 1997;12:343-346.
27. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. The nonosteogenic mouse pluripotent cell line C3H10T1/2 is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990;172:295-299.
28. Thies RS, Bauduy M, Ashtoon BA, Kurtzberg L, Wozney JM, Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992;130:1318-1324.
29. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic protein-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993;12:871-880.
30. Ohara N, Hayashi Y, Yamada S, Kim S-K, Matsunaga T, Yanagiguchi K, Ikeda T. Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 2004;25:1749-1754.
31. Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Esdaile JM. Randomized, double-blind, placebo-controlled glucosamine discontinuation in knee osteoarthritis. Arthritis Rheum 2004;51:738-745.
32. Owens S, Wagner P, Vangsness CT Jr. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg 2004;17:185-193.
33. McAlindon T, Formica M, La Valley M, Lehmer M, Kabbara K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: Results from an internet-based randomized double-blind controlled trial. Am J Med 2004;117:643-649.
34. Zerkak D, Dougados M. The use of glucosamine therapy in osteoarthritis. Curr Pain Headache Rep 2004;8:507-511.
35. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: A review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 2005;43:187-201.
36. Huang RP. Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Methods 2001;255:1-13.
37. Huang RP. Simultaneous detection of multiple proteins with an array-based enzyme-linked immunosorbent assay (ELISA) and enhanced chemiluminescence (ECL). Clin Chem Lab Med 2001;39:209-214.
38. Wang CC, Huang RP, Sommer M, Lisoukov H, Huang R, Lin Y, Burke J. Array-based multiplexed screening and quantitation of human cytokines and chemokines. J Proteome Res 2002;1:337-343.
39. Huang R, Lin Y, Wang CC, Gano J, Lin B, Shin Q, Boynton A, Burke J, Huang RP. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res 2002;62:2806-2812.
40. Imai M, Hayashi Y. Ultrastructure of wound healing following direct pulp capping with calcium-β-glycerophosphate (Ca-BGP). J Oral Pathol Med 1993;22:411-417.